Methscopolamine Bromide
NDC Package 81005-128-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Methscopolamine Bromide is methscopolamine is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). Marketed by Aarkish Pharmaceuticals Nj Inc., this product is identified by NDC 81005-128 and is authorized under FDA application ANDA216786.

Identification & Billing

NDC Package Code
81005-128-06
Package Description
60 TABLET in 1 BOTTLE
Product Code
81005-128
11-Digit Billing Format
81005012806

Clinical Specifications

Proprietary Name
Methscopolamine Bromide
Dosage Form
-
Usage Information
Methscopolamine is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Methscopolamine works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Methscopolamine belongs to a class of drugs known as anticholinergics.

Regulatory & Marketing

Labeler Name
Aarkish Pharmaceuticals Nj Inc.
FDA Application #
ANDA216786
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-26-2024
End Marketing Date
11-26-2024
Listing Expiration
11-26-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (81005-128). Click a package code to view its specific billing and regulatory data.

81005-128-10
1000 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81005-128-06 identifies a specific commercial package of 60 tablet in 1 bottle of Methscopolamine Bromide, labeled by Aarkish Pharmaceuticals Nj Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aarkish Pharmaceuticals Nj Inc. on February 26, 2024. The current certification is valid through November 26, 2024.

What are the primary indications for this medication?

Methscopolamine is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Methscopolamine works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Methscopolamine belongs to a class of drugs known as anticholinergics.

How is this Aarkish Pharmaceuticals Nj Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81005012806. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81005-128-06
11-Digit CMS (5-4-2)
81005-0128-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.